SCHEMBL19619249

SCHEMBL19619249

[N-]=[N+]=NC1CC(N=[N+]=[N-])[C@@H](O[C@H]2OC3COC4(CCCCC4)O[C@H]3C(O)C2N=[N+]=[N-])C2OC3(CCCCC3)OC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13873332 1.00 — —
SCHEMBL17323725 1.00 — —
SCHEMBL13890139 1.00 — —
SCHEMBL17323421 1.00 — —
SCHEMBL17323702 0.91 — —
SCHEMBL13890107 0.91 — —
SCHEMBL16882152 0.91 — —
SCHEMBL19619209 0.91 — —
SCHEMBL13873340 0.91 — —
SCHEMBL17320695 0.89 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180064743-A1 NOVEL AMINOGLYCOSIDES AND USES THEREOF IN THE TREATMENT OF GENETIC DISORDERS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2018-03-08 — — US disclosed
US-9821001-B2 Aminoglycosides and uses thereof in the treatment of genetic disorders TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2017-11-21 — — US disclosed
Send feedback